Philippe Lechat

10.6k total citations
168 papers, 7.3k citations indexed

About

Philippe Lechat is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Philippe Lechat has authored 168 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cardiology and Cardiovascular Medicine, 23 papers in Economics and Econometrics and 17 papers in Surgery. Recurrent topics in Philippe Lechat's work include Heart Failure Treatment and Management (33 papers), Cardiac electrophysiology and arrhythmias (24 papers) and Health Systems, Economic Evaluations, Quality of Life (19 papers). Philippe Lechat is often cited by papers focused on Heart Failure Treatment and Management (33 papers), Cardiac electrophysiology and arrhythmias (24 papers) and Health Systems, Economic Evaluations, Quality of Life (19 papers). Philippe Lechat collaborates with scholars based in France, Germany and Netherlands. Philippe Lechat's co-authors include Jean‐Sébastien Hulot, Anissa Bouzamondo, Henry Dargie, Alain Leizorovicz, Michel Cucherat, Gilles Montalescot, Zahir Amoura, N. Costedoat‐Chalumeau, Saı̈k Urien and Henry J. Dargie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Philippe Lechat

158 papers receiving 6.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Philippe Lechat 3.7k 952 806 560 512 168 7.3k
Anne‐Marie Dupuy 1.2k 0.3× 816 0.9× 914 1.1× 412 0.7× 183 0.4× 233 6.0k
Hiromichi Suzuki 2.9k 0.8× 1.1k 1.1× 1.4k 1.7× 257 0.5× 355 0.7× 408 8.5k
Kari Pulkki 2.6k 0.7× 1.2k 1.3× 2.0k 2.5× 182 0.3× 376 0.7× 206 8.0k
Andreas J. Flammer 2.3k 0.6× 941 1.0× 849 1.1× 236 0.4× 111 0.2× 136 6.1k
Daniel Duprez 5.2k 1.4× 1.9k 2.0× 560 0.7× 318 0.6× 225 0.4× 285 9.8k
Marc De Buyzere 5.8k 1.5× 1.8k 1.8× 1.1k 1.4× 127 0.2× 577 1.1× 315 10.4k
David J. Graham 1.6k 0.4× 982 1.0× 654 0.8× 298 0.5× 354 0.7× 115 5.6k
Wolfgang Lieb 1.9k 0.5× 737 0.8× 1.4k 1.8× 177 0.3× 247 0.5× 193 6.3k
Georg Noll 3.1k 0.8× 1.3k 1.4× 748 0.9× 398 0.7× 82 0.2× 136 6.5k
Vincent Mooser 1.6k 0.4× 1.5k 1.6× 2.0k 2.5× 311 0.6× 363 0.7× 170 10.2k

Countries citing papers authored by Philippe Lechat

Since Specialization
Citations

This map shows the geographic impact of Philippe Lechat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lechat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lechat more than expected).

Fields of papers citing papers by Philippe Lechat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lechat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lechat. The network helps show where Philippe Lechat may publish in the future.

Co-authorship network of co-authors of Philippe Lechat

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lechat. A scholar is included among the top collaborators of Philippe Lechat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lechat. Philippe Lechat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lechat, Philippe. (2020). Médicaments biosimilaires : enjeux réglementaires et impacts médicoéconomiques. Bulletin de l Académie Nationale de Médecine. 204(8). 877–883. 1 indexed citations
3.
Bocquet, François C., et al.. (2015). Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris. Value in Health. 18(7). A639–A639. 3 indexed citations
4.
Damman, Kevin, Adriaan A. Voors, Hans L. Hillege, et al.. (2010). Congestion in Chronic Systolic Heart Failure is Related to Renal Dysfunction and Increased Mortality. European Journal of Heart Failure. 12(9). 974–982. 127 indexed citations
5.
Castagno, Davide, Pardeep S. Jhund, John J.V. McMurray, et al.. (2010). Improved Survival with Bisoprolol in Patients with Heart Failure and Renal Impairment: An Analysis of the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) Trial. European Journal of Heart Failure. 12(6). 607–616. 62 indexed citations
6.
7.
Respaud, Renaud, Isabelle Benz‐de Bretagne, Hélène Blasco, et al.. (2009). Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of Multidrug Resistance Protein 2 (MRP2) function in humans. Journal of Chromatography B. 877(30). 3893–3898. 10 indexed citations
8.
Sassi, Yassine, Larissa Lipskaia, Grégoire Vandecasteele, et al.. (2008). Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. Journal of Clinical Investigation. 118(8). 2747–2757. 93 indexed citations
9.
Lelièvre, L. & Philippe Lechat. (2007). Mechanisms, manifestations, and management of digoxin toxicity. 9–11. 10 indexed citations
10.
Izzedine, Hassane, Jean‐Sébastien Hulot, Eric Villard, et al.. (2006). Association between ABCC2 Gene Haplotypes and Tenofovir‐Induced Proximal Tubulopathy. The Journal of Infectious Diseases. 194(11). 1481–1491. 174 indexed citations
11.
Zannad, Faı̈ez, Etienne Huvelle, Kenneth Dickstein, et al.. (2006). Left Bundle Branch Block as a Risk Factor for Progression to Heart Failure. European Journal of Heart Failure. 9(1). 7–14. 129 indexed citations
12.
Servais, Aude, Philippe Lechat, Noël Zahr, et al.. (2005). Effet de l'inhibition des transporteurs OAT1 et MRP2 sur la clairance de l'adéfovir. Néphrologie & Thérapeutique. 1(5). 296–300. 12 indexed citations
13.
Hulot, Jean‐Sébastien, Eric Villard, Ange Maguy, et al.. (2005). A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenetics and Genomics. 15(5). 277–285. 108 indexed citations
14.
Anker, Stefan D., Philippe Lechat, & Henry J. Dargie. (2003). Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: Results from the CIBIS-II study. Journal of the American College of Cardiology. 41(6). 156–157. 14 indexed citations
15.
Latini, Roberto, Serge Masson, Dianne Judd, et al.. (2002). The predictive value of combinations of different levels of brain natriuretic peptide and norepinephrine in the Val-HeFT trial. Journal of the American College of Cardiology. 39. 269–269. 1 indexed citations
16.
Trouvé, Pascal, et al.. (1998). Modifications of myocardial Na+,K+-ATPase isoforms and Na+/Ca2+ exchanger in aldosterone/salt-induced hypertension in guinea pigs. Cardiovascular Research. 38(2). 451–462. 16 indexed citations
17.
Lechat, Philippe, et al.. (1996). Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. Journal of the American College of Cardiology. 27(7). 1586–1591. 19 indexed citations
18.
Copie, Xavier, Jean‐Yves Le Heuzey, Philippe Lechat, et al.. (1995). 1031–34 Differential Effect of Bisoprolol on Heart Rate Variability According to Heart Rate in Patients with Heart Failure. Journal of the American College of Cardiology. 25(2). 417A–417A. 1 indexed citations
19.
Rouveix, B, et al.. (1991). Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 745–750. 44 indexed citations
20.
Lechat, Philippe, M Mudgett-Hunter, Michael N. Margolies, E Haber, & T.W.D. Smith. (1984). Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 210–213. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Dupuy Breakdown of academic impact, for papers by Hiromichi Suzuki Breakdown of academic impact, for papers by Kari Pulkki Breakdown of academic impact, for papers by Andreas J. Flammer Breakdown of academic impact, for papers by Daniel Duprez Breakdown of academic impact, for papers by Marc De Buyzere Breakdown of academic impact, for papers by David J. Graham Breakdown of academic impact, for papers by Wolfgang Lieb Breakdown of academic impact, for papers by Georg Noll Breakdown of academic impact, for papers by Vincent Mooser
Rankless by CCL
2026